For healthcare professionals only | Contact Us| Français

This non-accredited learning activity is supported by EMD Serono Canada, a member of Innovative Medicines Canada.
EMD Serono is a business of Merck KGaA, Darmstadt, Germany.

Self-reflection on current practice in patients with advanced urothelial carcinoma and alignment with latest evidence and guideline-directed care.